115 related articles for article (PubMed ID: 25565012)
1. Role of IL-10 and TGF-β in melanoma.
Wiguna AP; Walden P
Exp Dermatol; 2015 Mar; 24(3):209-14. PubMed ID: 25565012
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of transforming growth factor beta 1 and interleukin 10 in progressing and regressing areas of primary melanoma.
Conrad CT; Ernst NR; Dummer W; Bröcker EB; Becker JC
J Exp Clin Cancer Res; 1999 Jun; 18(2):225-32. PubMed ID: 10464712
[TBL] [Abstract][Full Text] [Related]
3. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.
Javelaud D; Mohammad KS; McKenna CR; Fournier P; Luciani F; Niewolna M; André J; Delmas V; Larue L; Guise TA; Mauviel A
Cancer Res; 2007 Mar; 67(5):2317-24. PubMed ID: 17332363
[TBL] [Abstract][Full Text] [Related]
4. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
Strengell M; Lehtonen A; Matikainen S; Julkunen I
J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
[TBL] [Abstract][Full Text] [Related]
6. Triptolide downregulates Treg cells and the level of IL-10, TGF-β, and VEGF in melanoma-bearing mice.
Liu B; Zhang H; Li J; Lu C; Chen G; Zhang G; Lu A; He X
Planta Med; 2013 Oct; 79(15):1401-7. PubMed ID: 23975869
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R
Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331
[TBL] [Abstract][Full Text] [Related]
8. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
[TBL] [Abstract][Full Text] [Related]
9. Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo.
Javelaud D; Delmas V; Möller M; Sextius P; André J; Menashi S; Larue L; Mauviel A
Oncogene; 2005 Nov; 24(51):7624-9. PubMed ID: 16007121
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of lentiviral-mediated RNA on the expression of Foxp3 protein in melanoma cells].
Chen DJ; Li XS; Zhao H; Shi XL; Zhang HH; Fan ZY; Yao YM; DU N
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):337-9. PubMed ID: 22482399
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
12. Friends or foes: IL-10 and TGF-β in melanoma.
Tikoo S; Haass NK
Exp Dermatol; 2015 Apr; 24(4):254-5. PubMed ID: 25661188
[No Abstract] [Full Text] [Related]
13. Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.
Yan BY; Garcet S; Gulati N; Kiecker F; Fuentes-Duculan J; Gilleaudeau P; Sullivan-Whalen M; Shemer A; Mitsui H; Krueger JG
Exp Dermatol; 2019 Jan; 28(1):35-44. PubMed ID: 30326165
[TBL] [Abstract][Full Text] [Related]
14. Exogenous IL-10 induces corneal transplantation immune tolerance by a mechanism associated with the altered Th1/Th2 cytokine ratio and the increased expression of TGF-β.
Li B; Tian L; Diao Y; Li X; Zhao L; Wang X
Mol Med Rep; 2014 Jun; 9(6):2245-50. PubMed ID: 24676597
[TBL] [Abstract][Full Text] [Related]
15. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
[TBL] [Abstract][Full Text] [Related]
16. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis.
Kitani A; Fuss I; Nakamura K; Kumaki F; Usui T; Strober W
J Exp Med; 2003 Oct; 198(8):1179-88. PubMed ID: 14557415
[TBL] [Abstract][Full Text] [Related]
18. Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions.
Gerlini G; Tun-Kyi A; Dudli C; Burg G; Pimpinelli N; Nestle FO
Am J Pathol; 2004 Dec; 165(6):1853-63. PubMed ID: 15579430
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7.
Dubinett SM; Huang M; Dhanani S; Economou JS; Wang J; Lee P; Sharma S; Dougherty GJ; McBride WH
J Natl Cancer Inst; 1995 Apr; 87(8):593-7. PubMed ID: 7752257
[TBL] [Abstract][Full Text] [Related]
20. Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration.
McNamee EN; Ryan KM; Griffin EW; González-Reyes RE; Ryan KJ; Harkin A; Connor TJ
Brain Behav Immun; 2010 May; 24(4):660-71. PubMed ID: 20193756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
